EventsThe 2nd International Electronic Conference on Medicinal Chemistry and Pharmaceutics
Published
This submission belongs to the session S8. Nanomedicine and Nanotechnology of the event The 2nd International Electronic Conference on Medicinal Chemistry and Pharmaceutics
Published date
28 Oct, 2026
Academic Editor
author-avatarFrancisco Javier Otero Espinar
Contribution&Funding
Conceptualization,
[Anton Vladimirovich Syroeshkin] ; [Oleg Vladimirovich Ledenev] ; [Tatiana Vladimirovna Grebennikova]
Methodology,
[Oleg Vladimirovich Ledenev] ; [Tatiana Vladimirovna Grebennikova] ; [Anton Vladimirovich Syroeshkin]
Software,
[Anton Vladimirovich Syroeshkin] ; [Tatiana Vladimirovna Grebennikova] ; [Oleg Vladimirovich Ledenev]
Validation,
[Anton Vladimirovich Syroeshkin] ; [Oleg Vladimirovich Ledenev] ; [Tatiana Vladimirovna Grebennikova]
Formal analysis,
[Anton Vladimirovich Syroeshkin] ; [Oleg Vladimirovich Ledenev] ; [Tatiana Vladimirovna Grebennikova]
Investigation,
[Anton Vladimirovich Syroeshkin] ; [Oleg Vladimirovich Ledenev] ; [Tatiana Vladimirovna Grebennikova]
Resources,
[Oleg Vladimirovich Ledenev] ; [Anton Vladimirovich Syroeshkin] ; [Tatiana Vladimirovna Grebennikova]
Data curation,
[Tatiana Vladimirovna Grebennikova] ; [Anton Vladimirovich Syroeshkin] ; [Oleg Vladimirovich Ledenev]
Writing - original draft,
[Anton Vladimirovich Syroeshkin] ; [Tatiana Vladimirovna Grebennikova] ; [Oleg Vladimirovich Ledenev]
Writing - review,
[editing] ; [Tatiana Vladimirovna Grebennikova] ; [Anton Vladimirovich Syroeshkin] ; [Oleg Vladimirovich Ledenev]
Visualization,
[Tatiana Vladimirovna Grebennikova] ; [Anton Vladimirovich Syroeshkin] ; [Oleg Vladimirovich Ledenev]
Supervision,
[Oleg Vladimirovich Ledenev] ; [Tatiana Vladimirovna Grebennikova] ; [Anton Vladimirovich Syroeshkin]
Project administration,
[Oleg Vladimirovich Ledenev] ; [Tatiana Vladimirovna Grebennikova] ; [Anton Vladimirovich Syroeshkin]
Funding acquisition,
[Oleg Vladimirovich Ledenev] ; [Tatiana Vladimirovna Grebennikova] ; [Anton Vladimirovich Syroeshkin]
Funding: --
Citation
Oleg Vladimirovich Ledenev, Tatiana Vladimirovna Grebennikova, Anton Vladimirovich Syroeshkin, Dynamic Light Scattering Detects Reproducible Process-Associated Shifts in Virus-Like Particle Size Profiles, in Proceedings of The 2nd International Electronic Conference on Medicinal Chemistry and Pharmaceutics, 1 November–30 November 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Dynamic Light Scattering Detects Reproducible Process-Associated Shifts in Virus-Like Particle Size Profiles

image
image
image
1. Laboratory of Molecular Diagnostics, National Research Center for Epidemiology and Microbiology named after Honorary Academician N. F. Gamaleya, Ministry of Health of the Russian Federation, Moscow, Russia
2. Department of Pharmaceutical and Toxicological Chemistry, Medical Institute, RUDN University, 6 Miklukho-Maklaya Street, Moscow, 117198, Russia
Abstract

Virus-like particles (VLPs) are complex nanoscale structures whose physicochemical characteristics can be affected by processing conditions. Particle-size distribution is therefore an informative parameter for monitoring the physical state and consistency of VLP preparations. In this study, dynamic light scattering (DLS) was evaluated as a rapid method for comparative characterization of VLP size profiles. Ten VLP preparations were analyzed using a Malvern Zetasizer, with seven replicate measurements performed for each preparation. The dominant intensity-weighted particle-size maximum ranged from 111.5 to 165.9 nm across the complete dataset. Within-preparation coefficients of variation ranged from 1.7% to 5.7%, indicating good repeatability of the measurements. Three matched pairs representing two defined processing states were available for direct comparison. In all three pairs, a consistent shift of the dominant particle-size maximum toward smaller diameters was observed: from 141.4 to 113.5 nm, from 150.0 to 113.1 nm, and from 149.9 to 117.0 nm. These changes corresponded to decreases of 19.7%, 24.6%, and 22.0%, respectively, with a mean relative shift of 22.1%. The results show that DLS can detect reproducible process-associated changes in the physical size profile of VLP preparations. Thus, DLS may serve as a rapid complementary tool for process development, comparability assessment, and routine physicochemical characterization of VLP-based biopharmaceuticals.

Keywords
virus-like particles; dynamic light scattering; particle-size distribution; process comparability; biopharmaceutical characterization
Opuntia ficus-indica-Loaded Chitosan/Zinc Oxide Nanocomposites: Physicochemical Characterization, Antibacterial, Antioxidant  and Photocatalytic Degradation Investigation
An Adapted Synthesis Method and Physicochemical Characterization of Colloidal Silver Dispersions for Prospective Biocidal Materials